Form D/A

View Original Filing

Notice of Exempt Offering of Securities

Item 1. Issuer's Identity

Name of Issuer:
OVASCIENCE, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2011

Previous Name(s)

Entity Type
CORPORATION

Item 2 Issuer Principal Place of Business and Contact Information

215 FIRST STREET
SUITE 240
CAMBRIDGE, MA 02142
Phone Number: subscription required

Item 3. Related Persons

Name
MICHELLE DIPP
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
CHRISTOPHER A. BLECK
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
SCOTT CHAPPEL
Address
subscription required
Relationship(s)
  • EXECUTIVE OFFICER
Clarification of Response

Item 3. Related Persons

Name
RICHARD ALDRICH
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JEFF CAPELLO
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
STEPHEN KRAUS
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JONATHAN TILLY
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
CHRISTOPH WESTPHAL
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 3. Related Persons

Name
JOHN SIMON
Address
subscription required
Relationship(s)
  • DIRECTOR
Clarification of Response

Item 4. Industry Group

BIOTECHNOLOGY

Item 5. Issuer Size

Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE

Item 6. Federal Exemptions and Exclusions Claimed

Item 7. Type of Filing

Amendment
Date of First Sale in this Offering:
06/21/2012

Item 8. Duration of Offering

Does the issuer intend this offering to last more than one year?
No

Item 9. Type(s) of Securities Offered

  • Equity

Item 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response

Item 11. Minimum Investment

Minimum Investment accepted from any outside investor
0

Item 12. Sales Compensation

Recipient
LEERINK SWANN LLC
Recipient CRD Number
39011
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
1 FEDERAL STREET
37TH FLOOR
BOSTON, MA 02110
States of Solicitation
  • ALL STATES

Item 12. Sales Compensation

Recipient
LIVINGSTON SECURITIES, LLC
Recipient CRD Number
147364
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
825 THIRD AVENUE
SUITE 223
NEW YORK, NY 10022
States of Solicitation
  • RI
  • DE
  • MS
  • NC
  • NY
  • CA
  • WY
  • NH
  • PA
  • OH
  • AR
  • CT
  • MD
  • MI
  • NJ
  • KY
  • AZ
  • TN
  • OR
  • NM
  • MA

Item 13. Offering and Sales Amounts

Total Offering Amount
3635946
Total Amount Sold
3635946
Total Remaining to be Sold
0
Clarification of Response

Item 14. Investors

Securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
80

Item 15. Sales Commissions and Finders' Fees Expenses

Sales Commissions:
218157.0
Finders' Fees
0.0
Clarification of Response

Item 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response

Signature and Submission

Issuer Name
OVASCIENCE, INC.
Issuer Signature
/S/ MICHELLE DIPP
Signer Name
MICHELLE DIPP
Signer Title
PRESIDENT AND CHIEF EXECUTIVE OFFICER
Signature Date
07/20/2012
WhaleWisdom Logo

Elevate your investments